Skip to content

Tagamyloid

Study validates beta amyloid as cause of dementia in both Alzheimer’s and Down syndrome.

More than five million Americans are living with Alzheimer’s disease (AD). Of them, 400,000 also have Down syndrome. People with Down syndrome (DS) represent the world’s largest population of predetermined … Continue Reading Study validates beta amyloid as cause of dementia in both Alzheimer’s and Down syndrome.

First ever large-scale human study validates multiple biomarkers for Alzheimer’s disease.

Through studying brain scans and cerebrospinal fluid of healthy adults researchers at Washington University have shown that changes in key biomarkers of Alzheimer’s disease during midlife can help identify those who … Continue Reading First ever large-scale human study validates multiple biomarkers for Alzheimer’s disease.

Alzheimer amyloid accumulation found in young adult brains for the first time.

Amyloid, an abnormal protein whose accumulation in the brain is a hallmark of Alzheimer’s disease, starts accumulating inside neurons of people as young as 20, a much younger age than … Continue Reading Alzheimer amyloid accumulation found in young adult brains for the first time.

Research suggests anti-inflammatory protein, interleukin 10, may trigger plaque in Alzheimer’s disease.

Inflammation has long been studied in Alzheimer’s, but in a counterintuitive finding, University of Florida researchers have uncovered the mechanism by which anti-inflammatory processes may trigger the disease.  This anti-inflammatory … Continue Reading Research suggests anti-inflammatory protein, interleukin 10, may trigger plaque in Alzheimer’s disease.